Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
Conditions
- Diabetes Mellitus, Type 1
Interventions
- DRUG: Empagliflozin medium placebo
- DRUG: Empagliflozin low placebo
- DRUG: Empagliflozin low placebo
- DRUG: Empagliflozin high placebo
- DRUG: Empagliflozin medium
- DRUG: Empagliflozin medium placebo
- DRUG: Empagliflozin high placebo
- DRUG: Empagliflozin high placebo
- DRUG: Empagliflozin medium placebo
- DRUG: Empagliflozin low placebo
- DRUG: Empagliflozin low
- DRUG: Empagliflozin high
Sponsor
Boehringer Ingelheim
Collaborators